BSC
RXRX icon

BOLTON SECURITIES CORPORATION’s Recursion Pharmaceuticals RXRX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34K Buy
+1,414
New +$5.46K ﹤0.01% 1791
2025
Q3 		$6.9K Buy
+1,414
New +$7.43K ﹤0.01% 1633
2025
Q1 		$5.29K Buy
+1,000
New +$7.29K ﹤0.01% 1567

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
MIC Capital Management (UK)
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's RXRX Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 1,414 shares worth $4.34K. The stake represents ﹤0.01% of the portfolio and ranks #1791 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in RXRX as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in RXRX in Q1 2025 and has held it in 3 quarters since. The position peaked at $6.9K in Q3 2025. 338 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 1,414 shares of Recursion Pharmaceuticals worth $4.34K as of Q1 2026.
  • Recursion Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1791 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Recursion Pharmaceuticals position peaked at $6.9K in Q3 2025.
  • 338 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.